Authors
Latest:
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesA case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Latest:
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesA case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Latest:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryUsing a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Latest:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryUsing a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Latest:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryUsing a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Latest:
Accelerating Genetic Medicine R&D Using MicrofluidicsThis review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Latest:
Accelerating Genetic Medicine R&D Using MicrofluidicsThis review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Latest:
Accelerating Genetic Medicine R&D Using MicrofluidicsThis review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Latest:
Accelerating Genetic Medicine R&D Using MicrofluidicsThis review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Latest:
Thermal Protection for Control-Room-Temperature ProductsThe authors discuss how to develop a cost-effective thermally protective packaging system.
Latest:
Control Viral Contaminants with Effective TestingDetecting viral contaminants in biologic-based medicines-and identifying their source-requires a holistic testing approach.
Latest:
Optimizing Protein Aggregate Analysis by SECA UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
Latest:
Optimizing Protein Aggregate Analysis by SECA UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
Latest:
Optimizing Protein Aggregate Analysis by SECA UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Molecular Cloning, Expression, and Purification of a Recombinant Fusion Protein (rNT-gp96-NT300). This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Latest:
Molecular Cloning, Expression, and Purification of a Recombinant Fusion Protein (rNT-gp96-NT300). This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Latest:
Molecular Cloning, Expression, and Purification of a Recombinant Fusion Protein (rNT-gp96-NT300). This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Latest:
Molecular Cloning, Expression, and Purification of a Recombinant Fusion Protein (rNT-gp96-NT300). This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Latest:
Sustaining Rapid Medicine Development: Lessons From A PandemicThis report explores rapid vaccine development during the pandemic and how process changes with the help of advanced manufacturing could aid the development of medicines.
Latest:
Connectors and Sealing Mechanisms—and Their Impact on Process ProtectionThe use of external retainers to enhance the seal between connectors and tubing is an essential component in single-use manufacturing systems.
Latest:
The Value of LMS in Driving Effective Risk Mitigation Principles through QMS and QRMInvesting in a single source enterprise-wide LMS to fuel risk management and mitigation offers multi-dimensional return on investment.
Latest:
Using Human Challenge Trials to Develop Flu VaccinesChallenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
